Q2 solutions and tasso collaborate to provide unique solutions for patients to accelerate adoption of decentralized clinical trials

Morrisville, n.c.--(business wire)--q2 solutions, a wholly-owned subsidiary of iqvia and a leading clinical trial laboratory services organization, today announced a transformative collaboration with tasso inc., a pioneer in clinical-grade, at-home, patient-centered blood testing, to develop diagnostic tests used in decentralized (virtual) clinical trials. these new laboratory-developed tests will use tasso's devices, enabling patients to collect their own blood using a virtually painless proce
IQV Ratings Summary
IQV Quant Ranking